BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 27354024)

  • 41. Non-Hodgkin Lymphoma - Nodal and Extranodal: 20-Year Comparative Mortality, Survival & Biologic Behavior Analysis by Age, Sex, Race, Stage, Cell Morphology/Histology, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 384,651 Total NHL Cases Including 261,144 Nodal and 123,507 Extranodal Cases for Diagnosis Years 1975-2016: (SEER*Stat 8.3.6).
    Milano AF
    J Insur Med; 2023 Jul; 50(1):1-35. PubMed ID: 37725503
    [TBL] [Abstract][Full Text] [Related]  

  • 42. B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.
    Snuderl M; Kolman OK; Chen YB; Hsu JJ; Ackerman AM; Dal Cin P; Ferry JA; Harris NL; Hasserjian RP; Zukerberg LR; Abramson JS; Hochberg EP; Lee H; Lee AI; Toomey CE; Sohani AR
    Am J Surg Pathol; 2010 Mar; 34(3):327-40. PubMed ID: 20118770
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lymphoid neoplasm incidence by WHO subtype in Australia 1982-2006.
    van Leeuwen MT; Turner JJ; Joske DJ; Falster MO; Srasuebkul P; Meagher NS; Grulich AE; Giles GG; Vajdic CM
    Int J Cancer; 2014 Nov; 135(9):2146-56. PubMed ID: 24639369
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multicenter retrospective analysis of 581 patients with primary intestinal non-hodgkin lymphoma from the Consortium for Improving Survival of Lymphoma (CISL).
    Kim SJ; Choi CW; Mun YC; Oh SY; Kang HJ; Lee SI; Won JH; Kim MK; Kwon JH; Kim JS; Kwak JY; Kwon JM; Hwang IG; Kim HJ; Lee JH; Oh S; Park KW; Suh C; Kim WS
    BMC Cancer; 2011 Jul; 11():321. PubMed ID: 21798075
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical characteristics and pathological classification of non-Hodgkin's lymphoma in Kuwait. Results of a collaborative study with the International Lymphoma Study Group (ILSG).
    Temmim L; Baker H; Al-Jarallah M; Manguno H; Madda JP; Sinowatz F
    Leuk Lymphoma; 2004 Sep; 45(9):1865-71. PubMed ID: 15223648
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Non-Hodgkin's lymphomas in Greece according to the WHO classification of lymphoid neoplasms. A retrospective analysis of 810 cases.
    Economopoulos T; Papageorgiou S; Dimopoulos MA; Pavlidis N; Tsatalas C; Symeonidis A; Foudoulakis A; Pectasides D; Rontogianni D; Rizos E; Chalkia P; Anagnostopoulos A; Melachrinou M; Papageorgiou E; Fountzilas G
    Acta Haematol; 2005; 113(2):97-103. PubMed ID: 15802887
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Frequencies of non-Hodgkin's lymphoma subtypes in Kuwait: comparisons between different ethnic groups.
    Ameen R; Sajnani KP; Albassami A; Refaat S
    Ann Hematol; 2010 Feb; 89(2):179-84. PubMed ID: 19711076
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinicopathological analysis of 501 non-Hodgkin's lymphomas in Korea according to the revised European-American classification of lymphoid neoplasms.
    Lee SS; Cho KJ; Kim CW; Kang YK
    Histopathology; 1999 Oct; 35(4):345-54. PubMed ID: 10564389
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [R.E.A.L. classification of non-Hodgkin lymphoma from the clinico-oncologic viewpoint].
    Meusers P; Brittinger G
    Praxis (Bern 1994); 1998 Jun; 87(23):793-800. PubMed ID: 9654985
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunophenotyping of Non-Hodgkin's lymphomas in Sudan.
    Hamid KH; Elduma AH; Mohamed BM; Salih MM
    Pan Afr Med J; 2014; 18():82. PubMed ID: 25400849
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lymphoid neoplasms in Bulgaria according to the WHO classification (2001). The experience of the National Center of Haematology.
    Shivarov V; Dimitrov J; Guenova M
    Haematologica; 2005 Dec; 90(12 Suppl):ELT07. PubMed ID: 16464764
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Primary extranodal non-Hodgkin lymphoma: A 3-year record-based descriptive study from a tertiary care center in Southern India.
    Mishra P; Das S; Kar R; Jacob SE; Basu D
    Indian J Pathol Microbiol; 2015; 58(3):296-300. PubMed ID: 26275249
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm.
    Chan JK; Sin VC; Wong KF; Ng CS; Tsang WY; Chan CH; Cheung MM; Lau WH
    Blood; 1997 Jun; 89(12):4501-13. PubMed ID: 9192774
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Non-Hodgkin's lymphoma by immunohistochemistry.
    Akhter A; Saleheen MS; Hussain M; Majid N; Rahman MR; Shermin S; Rajib RC; Huda MM; Haque N
    Mymensingh Med J; 2015 Jan; 24(1):108-14. PubMed ID: 25725676
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characteristics of 40 primary extranodal non-Hodgkin lymphomas of the oral cavity in perspective of the new WHO classification and the International Prognostic Index.
    van der Waal RI; Huijgens PC; van der Valk P; van der Waal I
    Int J Oral Maxillofac Surg; 2005 Jun; 34(4):391-5. PubMed ID: 16053848
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The results of histological and immunohistological studies of primary biopsies in 400 patients with non-Hodgkin's lymphoma in the North-West region of Russia (according to WHO classification)].
    Krivolapov IuA
    Ter Arkh; 2004; 76(7):64-70. PubMed ID: 15379131
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The epidemiology of lymphoma in Jordan: A nationwide population study of 4189 cases according to World Health Organization classification system.
    Aladily TN; Khreisat W; Ashukhaibi O; Alkhatib SM; Annab H; Tarawneh MS; Salman TS; Abu Farsakh H; Mahgoub R; Bustami N; Mansour AT; Aldeen AlRyalat S; Abbadi AS; Al-Fararjeh F; Sughayer M; Jaber O
    Hematol Oncol Stem Cell Ther; 2021 Dec; 14(4):336-342. PubMed ID: 33212024
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Head-and-neck stages I and II extranodal non-Hodgkin's lymphomas: real classification and selection for treatment modality.
    Sasai K; Yamabe H; Kokubo M; Shibata T; Oya N; Nagata Y; Hiraoka M
    Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):153-60. PubMed ID: 10924985
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinicopathological features of extranodal lymphomas: Kuwait experience.
    Temmim L; Baker H; Amanguno H; Madda JP; Sinowatz F
    Oncology; 2004; 67(5-6):382-9. PubMed ID: 15713994
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tanzanian malignant lymphomas: WHO classification, presentation, ploidy, proliferation and HIV/EBV association.
    Mwakigonja AR; Kaaya EE; Heiden T; Wannhoff G; Castro J; Pak F; Porwit A; Biberfeld P
    BMC Cancer; 2010 Jul; 10():344. PubMed ID: 20591198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.